Cibus (CBUS) Current Assets (2016 - 2026)
Cibus (CBUS) posted Current Assets of $12.1 million for Q4 2025, down 54.01% sequentially from $26.2 million in Q3 2025, and down 28.78% YoY from $16.9 million in Q4 2024.
Cibus (CBUS) Current Assets (2016 - 2026) Analysis & Trends
Cibus has reported Current Assets for 10 years, with the latest figure at $12.1 million in Q4 2025.
- Quarterly Current Assets fell 28.78% year-over-year to $12.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $12.1 million (down 28.78% YoY) and the FY2025 annual result came in at $12.1 million, down 28.78% from the prior year.
- Current Assets retreated to $12.1 million in Q4 2025 per CBUS's latest filing, from $26.2 million in the prior quarter.
- Over five years, Current Assets peaked at $54.8 million in Q2 2023 and troughed at $2.6 million in Q1 2023.
- A 5-year average of $23.5 million and a median of $25.4 million in 2021 frame the typical range for Current Assets.
- The sharpest annual moves came in 2023 and 2024: Current Assets plunged 86.39% in 2023, then soared 934.34% in 2024.
- Over 5 years, Current Assets stood at $15.2 million in 2021, then slumped by 72.78% to $4.1 million in 2022, then surged by 752.37% to $35.2 million in 2023, then tumbled by 51.89% to $16.9 million in 2024, then dropped by 28.78% to $12.1 million in 2025.
- According to Business Quant data, Current Assets over the past three periods registered $12.1 million, $26.2 million, and $39.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 4.62 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.63 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.76 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 18.80 Bn |
| 10 | Cibus | 131.25 Mn | 110.82 Mn | - | 23.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.46 Mn |
| Dec 31, 2025 | 12.07 Mn |
| Sep 30, 2025 | 26.24 Mn |
| Jun 30, 2025 | 39.84 Mn |
| Mar 31, 2025 | 25.88 Mn |
| Dec 31, 2024 | 16.95 Mn |
| Sep 30, 2024 | 31.57 Mn |
| Jun 30, 2024 | 33.10 Mn |
| Mar 31, 2024 | 26.72 Mn |
| Dec 31, 2023 | 35.22 Mn |
| Sep 30, 2023 | 34.47 Mn |
| Jun 30, 2023 | 54.85 Mn |
| Mar 31, 2023 | 2.58 Mn |
| Dec 31, 2022 | 4.13 Mn |
| Sep 30, 2022 | 7.94 Mn |
| Jun 30, 2022 | 12.86 Mn |
| Mar 31, 2022 | 18.97 Mn |
| Dec 31, 2021 | 15.18 Mn |
| Sep 30, 2021 | 17.25 Mn |
| Jun 30, 2021 | 24.97 Mn |